The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in mice

Anna Maria Malfitano, Chiara Laezza, Mario Galgani, Giuseppe Matarese, Alba D'Alessandro, Patrizia Gazzerro, Maurizio Bifulco

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in mice'. Together they form a unique fingerprint.

Medicine & Life Sciences